2026-01-26 - Analysis Report
**Company Overview**
Accenture is a global management consulting and professional services firm.

**Return Comparison**
- Cumulative return of review stock (ACN): 53.33%
- Cumulative return of comparison stock (S&P 500, VOO): 126.41%
- Divergence: -72.10
- Relative divergence: 11.00%

The cumulative return of ACN is lower than that of VOO, with a divergence of -72.10. This suggests that ACN has underperformed the S&P 500 in the given time period.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 12.0% | 19.8% | 0.0% | 1.1 | 87.5B |
| 2017-2019  | 56.0% | 19.8% | 30.0% | 1.1 | 130.6B |
| 2018-2020  | 47.0% | 32.3% | 23.0% | 1.0 | 162.0B |
| 2019-2021  | 146.0% | 32.3% | 81.0% | 1.0 | 257.1B |
| 2020-2022  | 8.0% | 34.3% | 1.0% | 1.1 | 165.5B |
| 2021-2023  | 32.0% | 34.3% | 12.0% | 1.2 | 217.6B |
| 2022-2024  | -31.0% | 25.8% | -60.0% | 1.1 | 218.2B |
| 2023-2025  | -23.0% | 38.9% | -98.0% | 0.9 | 166.4B |

**Recent Stock Price Fluctuations**
- Close: $281.07
- Last-market: -1.41
- 5-day SMA: $281.16
- 20-day SMA: $276.35
- 60-day SMA: $262.79

The short-term moving averages (5-day and 20-day) are higher than the stock's closing price, while the 60-day moving average is lower. This indicates a short-term upward trend.

**RSI, PPO Analysis**
- Market Risk Indicator (MRI): 0.70
- RSI: 64.02
- PPO: -0.09
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium
- Recent relative divergence change: -1.50 (worsening)
- 7-day Rank change: 0 (flat)
- 7-day Dynamic Expected Return change: 0.00 (flat)
- Expected Return: 77.80%

The MRI is at a medium risk level, indicating a relatively balanced market. The RSI is above 50, suggesting an upward trend.

**Recent News & Significant Events**

- 2026-01-23: Accenture (ACN) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance (news.google.com)
- 2026-01-25: Accenture PLC $ACN Shares Bought by Provident Trust Co. - MarketBeat (news.google.com)
- 2026-01-21: Accenture (ACN) Stock Trades Up, Here Is Why - Finviz (news.google.com)
- 2026-01-22: Accenture: I'm Starting A Position (Technical Analysis) - Seeking Alpha (news.google.com)
- 2026-01-24: Here's How Much You Would Have Made Owning Accenture Stock In The Last 20 Years - Sahm (news.google.com)
- 2026-01-24: What Accenture (ACN)'s Sovereign AI Data Center Role Means For Shareholders - simplywall.st (news.google.com)

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.04 (~Buy)
- Opinions: 27
- Target Price (avg/high/low): 291.42 / 330.00 / 210.00

The analyst consensus is to buy Accenture, with a target price range of 291.42 to 330.00.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-12-18 | 3.57 | $18.74B |
| 2025-10-10 | 2.27 | $17.60B |
| 2025-06-20 | 3.52 | $17.73B |
| 2025-10-10 | 3.52 | $17.73B |
| 2025-03-20 | 2.85 | $16.66B |

Accenture's earnings have shown a upward trend, with increasing revenue and EPS.

**Financial Information: Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $18.74B | 33.07% |
| 2025-08-31 | $17.60B | 31.89% |
| 2025-05-31 | $17.73B | 32.87% |
| 2025-02-28 | $16.66B | 29.86% |
| 2024-11-30 | $17.69B | 32.92% |

Accenture's revenue continues to increase, with a profit margin range of 29.86% to 33.07%.

**Financial Information: Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $30.87B | 7.16% |
| 2025-08-31 | $31.20B | 4.53% |
| 2025-05-31 | $30.55B | 7.19% |
| 2025-02-28 | $29.25B | 6.11% |
| 2024-11-30 | $29.19B | 7.81% |

Accenture's equity has shown a upward trend, with a ROE range of 4.53% to 7.81%.

**Comprehensive Analysis (Summary of previous items)**

Accenture's cumulative return is lower than that of the S&P 500, with a divergence of -72.10. The RSI is above 50, suggesting an upward trend. The short-term moving averages are higher than the stock's closing price, while the 60-day moving average is lower. The analyst consensus is to buy Accenture, with a target price range of 291.42 to 330.00. Accenture's earnings have shown a upward trend, with increasing revenue and EPS. The equity has shown a upward trend, with a ROE range of 4.53% to 7.81%.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.